chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I have had a lingering "Vaccine Brain Fog" since my shot - after the first shot, and it is noticeably worse after the 2nd shot.  It feels like I have a hangover or head cold, stuffy head.; tired; hangover or head cold, stuffy head; hangover or head cold, stuffy head; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A female patient received bnt162b2 (BNT162B2), administration date May2021 (Batch/Lot number: unknown) as dose 2, single and administration date Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious) with onset 2021, outcome "unknown", described as "I have had a lingering "Vaccine Brain Fog" since my shot - after the first shot, and it is noticeably worse after the 2nd shot. It feels like I have a hangover or head cold, stuffy head."; FATIGUE (non-serious) with onset 2021, outcome "unknown", described as "tired"; HANGOVER (non-serious), NASOPHARYNGITIS (non-serious) all with onset 2021, outcome "unknown" and all described as "hangover or head cold, stuffy head".  Additional Information: Patient's mother (reporter) stated that both mother and her daughter felt the same way. Patient received her shots at the same location just a week after reporter. They had a lingering vaccine brain fog since first shot and its noticeably worse after second shot. It feels like they have hangover or head cold, stuffy head. They are constantly tired as well.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
After vaccine started feeling unstable, with a headache and feverish and went to bed early and took Tylenol. I woke up during the night because my arm was throbbing and painful and it woke me up. I put a cold compress on it and I took an Ambien and fell back asleep. In the morning it was still a little swollen. Tried to rest the arm as much as I could. It dissipated over time. When I went to my physical therapist and she suggested that it could be a result of the vaccine.
rash on lower back; Breakouts; This is a spontaneous report from a non-contactable 47-year-old, female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm 15Mar2021 at 02:00AM (at the age of 47-year-old) as a single dose for COVID-19 vaccination. Medical history included hypothyroidism. It was reported that the patient was not pregnant at the time of vaccination. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. The patient received many other medications (unspecified) within 2 weeks of vaccination. It was unknown whether the patient have any allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient has not tested for COVID-19 since having the vaccine. The patient's concomitant medications were not reported. On 15Mar2021, the patient experienced breakouts and rash on lower back (Skin breakout) 4-5 hours after vaccination. The patient was treated for the breakouts and rash on lower back (Skin breakout) with Antihistamine (MANUFACRURER UNKNOWN). The clinical outcome of the breakouts and rash on lower back (Skin breakout) was recovering. No follow-up attempts are needed. No further information is expected.
pt recv vax 2JUN95 & 6JUN95 pt exp gen chickenpox rash & temp between 100 & 101; No further details were provided;
Baseball size lump at vacc. site - body aches all over, fever, itching at site. Arm very tender.
PNEUMOVAX 23 administered 9/6/12. Pt called 9/7 complaining of pain. Advised ice & MOTRIN went to ER 9/10/12. MD gave 1 hour IV antibiotics for staph; Primary MD gave CIPRO 9/10/12.
No symptoms at time of vaccine other than an itchy arm at the site of injection. Then no symptoms until my annual mammogram on June 10, 2021 of hospital with a call back and biopsy finding Invasive Ductal Carcinoma on the left breast. The vaccine was given in my left arm.
Extreme low back pain; Extreme low back pain and worsening of joint inflammation; 3 episodes of recurrent injection site pain; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP). The reporter is the patient.  A 56 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 03Mar2021 (Lot number: EN6203) at the age of 56 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing), notes: Prior to vaccination, patient was diagnosed with COVID-19; "SI joint inflammation" (ongoing), notes: SI joint inflammation; "Low back arthritis" (ongoing), notes: Low back arthritis. There were no concomitant medications.  The following information was reported: BACK PAIN (non-serious) with onset 10Mar2021, outcome "recovered with sequelae" (2021), described as "Extreme low back pain"; ARTHRITIS (non-serious) with onset 10Mar2021, outcome "recovered with sequelae" (2021), described as "Extreme low back pain and worsening of joint inflammation"; VACCINATION SITE PAIN (non-serious) with onset 10Mar2021, outcome "recovered with sequelae" (2021), described as "3 episodes of recurrent injection site pain". It was unknown if therapeutic measures were taken as a result of back pain, arthritis, vaccination site pain.  Additional information: Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. The patient had no known allergies. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was diagnosed with COVID-19 and since the vaccination, patient has not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Subject in pneumococcal vaccine trial, with severe COPD, was hospitalized with Cellulitis of leg. Vaccination took place 11.07.2007. According to the physician the relationship is Unlikely. We would be happy to fax you the Studys SAE report.
3 generalized seizures at 9pm, 10:30pm and again the following day (12/15/2011) at 4pm.
Since then I have had a deep, constant pain that runs down the length of my arm, almost as if I badly strained a ligament. It lasted 10 days. It seems to originate in my rotator cuff making certain movements give me acute pain. I have been taking Tylenol to sleep, but I usually wake up from the pain exactly 6 hours after I take it. I have been using ice also.
This spontaneous report was received from a registered nurse via medical assistant and refers to a 13-month-old female patient. The patient's pertinent medical history, concurrent conditions, concomitant medications, past drugs and drug allergies were not reported. On 28-SEP-2017, the patient was vaccinated with improperly stored M-M-R II (lot # M034387; expiry date: 19-JUL-2018) (dosing details were not provided) for prophylaxis. Temperature excursion details of the vaccine were not provided. This is one of the several reports received from the same source. Sender's Comments: US-009507513-1709USA008861: US-009507513-1710USA013424: US-009507513-1710USA013470: US-009507513-1710USA013465: US-009507513-1710USA013440: US-009507513-1710USA013468: US-009507513-1710USA013442: US-009507513-1710USA013445: US-009507513-1710USA013460: US-009507513-1710USA013463: US-009507513-1710USA013464: US-009507513-1710USA013438: US-009507513-1710USA013439: US-009507513-1710USA013450: US-009507513-1710USA013430: US-009507513-1710USA013469: US-009507513-1710USA013467: US-009507513-1710USA013435: US-009507513-1710USA013434: US-009507513-1710USA013432: US-009507513-1710USA013428: US-009507513-1710USA013437: US-009507513-1710USA013441: US-009507513-1710USA013443: US-009507513-1710USA013444: US-009507513-1710USA013446: US-009507513-1710USA013447: US-009507513-1710USA013448: US-009507513-1710USA013436: US-009507513-1710USA013449: US-009507513-1710USA013451: US-009507513-1710USA013452: US-009507513-1710USA013454: US-009507513-1710USA013455: US-009507513-1710USA013456: US-009507513-1710USA013457: US-009507513-1710USA013458: US-009507513-1710USA013459: US-009507513-1710USA013461: US-009507513-1710USA013462: US-009507513-1710USA013466: US-009507513-1710USA013427: US-009507513-1710USA013471: US-009507513-1710USA013472: US-009507513-1710USA013473: US-009507513-1710USA013474: US-009507513-1710USA013475: US-009507513-1710USA013476: US-009507513-1710USA013425: US-009507513-1710USA013433: US-009507513-1710USA013423: US-009507513-1710USA013040: US-009507513-1710USA013426: US-009507513-1710USA013429: US-009507513-1710USA013431: US-009507513-1709USA008666: Original Case: 1709USA008666: US-009507513-1710USA014650: Original Case: 1710USA014649: US-009507513-1710USA014651: Original Case: 1710USA014649: US-009507513-1710USA014649: Original Case: 1710USA014649.
Bronchoconstriction requiring use of rescue albuterol inhaler not previously needed for at least 5 years
Monovalent Covid-19 (Pfizer and Moderna) boosters were administered to 24 patients after FDA removed their authorization; these errors occured from 9/1/22 to 9/7/2022. No more monovalent booster vaccines administeredafter we received the Bivalent Boosters on 9/8/2022. No adverse event noted. RM,RN.
a few hours after vaccine got high fever, extreme fatigue, and joint pain. Was really bad for 24hr at 48hr began to improve. At two weeks out I have excessive sweating.  It is gross. I drip.
approxmately 1:30 Pm the resident passed away; This is a spontaneous report from a Pfizer sponsored program. A non-contactable consumer reported that a female patient of an unspecified age (reported as 85 without unit) received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL0140), intramuscular at left arm on 29Dec2020 11:29 at single dose for COVID-19 immunization. Medical history included dementia, aphasia, type 2 diabetes mellitus (DM), iron deficiency, asthenia, osteoporosis, polyneuropathy, anxiety, Major depressive disorder (MDD). Concomitant medication included gabapentin, memantine. The patient had allergies to codiene, phenobarbital, penicillin. The vaccine was administrated with no immediate adverse reaction at 11:29. Vaccine screening questions were completed and resident was not feeling sick and temperature was 98F. At approximately 13:30 on 29Dec2020, the resident passed away.  It was not reported if an autopsy was performed.  No follow-up attempts are possible. No further information is expected. ; Reported Cause(s) of Death: approxmately 1:30 Pm the resident passed away
Developed fatigue, back pain, chest pain, nausea and vomiting the morning after the vaccination. On Saturday 4/17, I awoke feeling some better. Performed my daily routines uneventfully other than just not feeling 100 percent. By that evening the chest pain returned. On 4/18, I awoke with severe chest pains. I then presented to the ER where was presumed I was having a heart attack vs. acute pericarditis/myocarditis.
Patient hospitalized for COVID-19 infection after COVID-19 immunization. Administered remdesivir and steroids and anticoagulated. Discharged to home medically stable.
Achy joints; Fatigue; Pain at injection site; This is a spontaneous report from a non-contactable consumer, the patient. A 49-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the right arm on 04Apr2021 at 11:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not provided. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on unknown an date, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced achy joints, fatigue and pain at injection site. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event's achy joints, fatigue and pain at injection site was not recovered.   No follow-up attempts are possible; No further information is expected.
COVID(+) WITH SYMPTOMS SORE THROAT DIARRHEA FATIGUE HEADACHE Narrative:
Fatigue in afternoon following injections.  Then proceeded by chills, fever, and nausea during the night (including dry vomiting).  Chills laster another day, and fatigue (frequent naps) lasted for two more days.  Total of 4 days of adverse conditions.
Joint pain, rash on thigh, itchy rash and swelling on ankle Of same leg
Swelling tongue-sore throat-swollen glands-neck began about 20 hours after shot-lasted 5 days.
Severely sick after vaccine; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  An adult female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "Severely sick after vaccine".  Additional information: Patient was tired of all of them because even though she got the vaccine & did everything to prevent her family from getting Covid & she got severely sick.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a physician concerning a pediatric patient with celiac disease who on unspecified date was vaccinated with the series for RECOMBIVAX HB (manufacturer unknown) but was  not seroconvert. It was unspecified if the patient sought medical attention. At the time of reporting the outcome of the patient was unknown. All telephone attempts to obtain follow-up information have been unsuccessful. This is one of several reports from the same source. Additional information has been requested.
Intraoperative venous injury; Memory impaired; Dental disorder NOS; back pain; Loss of personal independence in daily activities; Postoperative bruise; Procedural site pain; Postoperative thrombosis; Venous peripheral insufficiency; This is a Solicited report from a non-contactable consumer (patient) based on the information received by Pfizer from AbbVie (MFR Control No: 21K-163-3951457-00).   A 53-year-old female patient received bnt162b2 (BNT162B2), dose 1 intramuscular on 17Mar2021 (Lot Number: EN6208) as single dose, dose 2 intramuscular on 07Apr2021 (Lot Number: AW0151) as single dose for covid-19 immunisation; adalimumab (HUMIRA), subcutaneous from an unspecified date to an unspecified date, at UNK, Discontinued, subcutaneous from unknown date (reported as 10Jul2021 which is a future date) to an unspecified date, at 0.4 mL, weekly(40mg, weekly) for Moderate to severe Hidradenitis suppurativa and Moderate to severe Rheumatoid arthritis.   Medical history included abstains from alcohol, leg surgery, fibromyalgia, high cholesterol, penicillin allergy manifested by hives, smoker (smoker-ten sticks of cigarettes per day). Concomitant medications included paracetamol (TYLENOL); montelukast (MONTELUKAST); omeprazole (OMEPRAZOLE); vitamin d3 (VITAMIN D3); loratadine (LORATADINE); folic acid (FOLIC ACID); pregabalin (LYRICA); fluticasone propionate, salmeterol xinafoate (ADVAIR); methotrexate (METHOTREXATE); ibuprofen (MOTRIN CHILDREN); salbutamol (ALBUTEROL HFA).   The patient experienced postoperative thrombosis on 06Apr2021 with outcome of not recovered , venous peripheral insufficiency on 06Apr2021 with outcome of not recovered , venous operation on an unspecified date with outcome of not recovered, procedural site pain on May2021 with outcome of recovering, intraoperative venous injury on an unspecified date with outcome of not recovered , postoperative bruise on May2021 with outcome of recovered in 2021, memory impaired on an unspecified date with outcome of not recovered , dental disorder nos on an unspecified date with outcome of not recovered , back pain on an unspecified date with outcome of unknown , loss of personal independence in daily activities on an unspecified date with outcome of unknown.  The patient underwent lab tests and procedures which included ultrasound: Insufficient Vein on May2021.  The action taken in response to the event for bnt162b2 was not applicable, for adalimumab was unknown.  The reporter's assessment of the causal relationship of the events with the suspect product was not provided at the time of this report. Since no determination has been received, the case is managed based on the company causality assessment.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: There is no reasonable possibility that reported events Postoperative thrombosis, Venous peripheral insufficiency, Procedural site pain, Intraoperative venous injury, Postoperative bruise, Memory impaired, dental disorder, back pain and loss of personal independence are related to BNT162B2. The events are likely intercurrent conditions.
Shortness of breath; Chest pain; Huge baseball size lump at the injection site was very hard; After second vaccine appeared a huge baseball sized lump at injection site; Huge baseball size lump at the injection site was very sore; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), CHEST PAIN (Chest pain), VACCINATION SITE INDURATION (Huge baseball size lump at the injection site was very hard), VACCINATION SITE SWELLING (After second vaccine appeared a huge baseball sized lump at injection site) and VACCINATION SITE PAIN (Huge baseball size lump at the injection site was very sore) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. o14cz1A and o4ob218) for COVID-19 vaccination.     No Medical History information was reported.   On 25-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, the patient experienced DYSPNOEA (Shortness of breath), CHEST PAIN (Chest pain), VACCINATION SITE INDURATION (Huge baseball size lump at the injection site was very hard), VACCINATION SITE SWELLING (After second vaccine appeared a huge baseball sized lump at injection site) and VACCINATION SITE PAIN (Huge baseball size lump at the injection site was very sore). On 25-May-2021, DYSPNOEA (Shortness of breath) and CHEST PAIN (Chest pain) had resolved. At the time of the report, VACCINATION SITE INDURATION (Huge baseball size lump at the injection site was very hard), VACCINATION SITE SWELLING (After second vaccine appeared a huge baseball sized lump at injection site) and VACCINATION SITE PAIN (Huge baseball size lump at the injection site was very sore) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product use was provided by the reporter.  No treatment medication was provided.  Action take with mRNA-1273 in response to the events were not applicable.  On the night of vaccination day she went to the Amita Community Hospital ER, located in Munster, Indiana, with chest pain and shortness of breath, and they took tests. She had a really hard time breathing, and these side effects were resolved, after her release the same day.
PATIENT IS NOT EXPERIENCING ANY SIGNIFICANT SIDE/ADVERSE EFFECTS, BUT SORE LEFT ARM. HE IS FINE OTHERWISE. HE WAS GIVEN THE COVID-19 SHOT INSTEAD OF SHINGRIX SHOT BY MISTAKE.
Same as my first shot feeling lethargic, exhausted, feeling ill, bad aches, feverish. Just all around don't feel good at all.
ARM STILL SORE; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 02-OCT-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On OCT-2021, the patient experienced arm still sore. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from arm still sore. This report was non-serious. This case, from the same reporter is linked to 20211110578.
right arm hurt; right shoulder hurt; chest pain; fever all night of 101.8; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever all night of 101.8), PAIN IN EXTREMITY (right arm hurt), ARTHRALGIA (right shoulder hurt) and CHEST PAIN (chest pain) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event on 03-Mar-2021.    On 01-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 01-Mar-2021, the patient experienced PYREXIA (fever all night of 101.8). On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (right arm hurt), ARTHRALGIA (right shoulder hurt) and CHEST PAIN (chest pain).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
This spontaneous report as received from a registered nurse. The nurse stated doses of RECOMBIVAX HB (doses unspecified in series) were administered between 24-JUL-2014 and 01-AUG-2014, doses were exposed to -1.5 C for 5 hours. No adverse effects reported. Nurse stated she had no patient specific information. This is one of several reports received from the same reporter. Additional information has been requested.
I had a severe asthma attack, but this was not right after the vaccine, it was 5 weeks later, and could have been brought on by other allergies.  I was coughing uncontrollably, sneezing, nasal discharge, and wheezing with audible rumble in my chest.  Visited urgent care after all self care medications were not helping.  Was given 5 days of steroids and injection of steroid.